What should you know about INSS neuroblastoma?

The International Neuroblastoma Staging System, often shortened to INSS, is an older staging framework for neuroblastoma. It uses information gathered during surgery, the amount of tumour that could be removed, lymph-node findings, and whether disease is found beyond its original region. The stage is only one part of risk assessment.

Modern teams may also use a newer image-defined system and biological features such as tumour genetics, age at diagnosis, and the tumour’s microscopic appearance. Ask which staging system is written in the report, because the meaning of a stage depends on the system used.

Ask the paediatric oncology team to translate the stage into a treatment plan. Neuroblastoma care may involve observation for selected situations, surgery to remove tumour, chemotherapy, radiotherapy, or targeted radioisotope therapy. The combination depends on risk grouping, tumour biology, location, symptoms, and response to treatment.

Keep the pathology, imaging, and operative reports together. A second review at a specialist centre may help when the diagnosis or stage is complex. Treatment planning should also cover pain, nutrition, infection precautions, school support, and practical help for the child and family.

Call the oncology team promptly for fever during treatment, new weakness, worsening pain, persistent vomiting, reduced drinking, unusual bruising, or a child who becomes much less alert. Seek emergency help for breathing difficulty, a seizure, sudden paralysis, severe dehydration, or a child who cannot be woken normally.

Which staging system is being used? What is the INSS stage and what findings produced it? What are the tumour biology and risk group? Could surgery remove the tumour safely? Why is chemotherapy, radiotherapy, or targeted radioisotope therapy being considered? How will response be monitored?